StockDriftsStockDriftsTop 22 Acorn Capital Advisors LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| TERN | TERNS PHARMACEUTICALS INC | 26.17% | 1.75M | $92.1M | +0.00%(+0) | $6.94(+662.97%) | 2026-03-31 | |
| CGON | CG ONCOLOGY INC | 21.77% | 1.13M | $76.6M | -0.09%(-1.00K) | $33.20(+111.90%) | 2026-03-31 | |
| URGN | UROGEN PHARMA LTD | 8.55% | 1.67M | $30.1M | +15.53%(+225.00K) | $14.02(+171.24%) | 2026-03-31 | |
| PBYI | PUMA BIOTECHNOLOGY INC | 7.5% | 4.13M | $26.4M | +0.00%(+0) | $2.82(+192.65%) | 2026-03-31 | |
| TRVI | TREVI THERAPEUTICS INC | 7.27% | 2.14M | $25.6M | +0.00%(+0) | $3.83(+368.28%) | 2026-03-31 | |
| CADL | CANDEL THERAPEUTICS INC | 4.89% | 3.50M | $17.2M | +35.55%(+917.43K) | $6.82(+44.12%) | 2026-03-31 | |
| BCAX | BICARA THERAPEUTICS | 3.64% | 643.4K | $12.8M | +0.00%(+0) | $21.44(+35.23%) | 2026-03-31 | |
| OKUR | ONKURE THERAPEUTICS INC | 3.34% | 2.84M | $11.8M | +0.00%(+0) | $8.18(-44.00%) | 2026-03-31 | |
| JBIO | JADE BIOSCEINCES INC | 3.14% | 786.8K | $11.1M | new | $14.74(+45.93%) | 2026-03-31 | |
| TARA | PROTARA THERAPEUTICS INC | 2.59% | 1.75M | $9.1M | +0.00%(+0) | $3.62(+12.08%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +24.75% | +94.16% |
| Top 20 Holdings Unweighted | +10.95% | +36.59% |
Sign up free to track Acorn Capital Advisors LLC, compare funds side by side, and get alerts the moment positions change.